Item 2.02. Results of Operations and Financial Condition.
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced its operational
results for the fourth quarter and year ended December 31, 2008. A copy of its
press release is attached hereto as Exhibit 99.1.
The information furnished pursuant to Item 2.02 in this Form 8-K shall not be
deemed to be "filed" for the purposes of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section, unless we
specifically incorporate it by reference in a document filed under the
Securities Act of 1933 or the Exchange Act. We undertake no duty or obligation
to publicly update or revise the information furnished pursuant to Item 2.02 in
this Form 8-K.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Press Release dated March 13, 2009
|
Add
PGNX to Portfolio
Set Alert
Email to a
Friend